Earnings calendar

Madrigal Pharmaceuticals, Inc. (MDGL) earnings: date, estimates, results and stock reactions

Over the last 12 reports the stock moved 12.3% on average (either way), rising 5 times and falling 7. EPS beat estimates 8 of 11 times; revenue 7 of 10. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q4 FY20262026-11-031.83-0.86+312.0%431.3M404.2M-7.1%
Q3 FY20262026-07-30-1.99-2.68+25.7%364.3M352.1M-14.5%
Q2 FY20262026-05-06-3.25-3.61+10.0%311.3M301.1M+6.4%
Q1 FY20262026-02-19-2.570.04n/a321.1M312.5M-11.5%
Q4 FY20252025-11-04-5.08-2.04-149.4%287.3M245.0M+15.4%
Q3 FY20252025-08-05-1.90-3.48+45.4%212.8M243.5M+8.3%
Q2 FY20252025-05-01-3.32-3.62+8.3%137.3M158.9M-5.5%
Q1 FY20252025-02-26-2.71-4.32+37.3%103.3M97.8M+8.5%

MDGL stock report · Earnings calendar